Reagenzgläser
Vesalius Biocapital

A European life sciences venture capital investor

.

About us

News

Vesalius News

11/16/2023
Memo Therapeutics: CEO Erik van den Berg
read more
11/02/2023
Memo Therapeutics: CHF 25 Million Financing
read more
10/04/2023
Rejuvenate Biomed: Positive results
read more
.

xxnoxx_zaehler